Italia markets open in 6 hours 35 minutes

Dow Jones
39.872,99
+66,22(+0,17%)
Nasdaq
16.832,62
+37,75(+0,22%)
Nikkei 225
38.704,79
-242,14(-0,62%)
EUR/USD
1,0860
+0,0001(+0,01%)
Bitcoin EUR
64.605,72
-1.277,43(-1,94%)
CMC Crypto 200
1.525,77
+37,22(+2,50%)

NVCR Dec 2025 12.500 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

6,90

0,00

(0,00%)

In data: 03:56PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in